In current challenging pharmaceutical market, finding and influencing the right target audience is undoubtedly a crucial factor to lead success in drug commercialization. By doing so, it also leads a both effective and efficient investment and return in terms of Customer Relationship Management. BalDr’s Key Opinion Leader Mapping (KOLM) Solution can help our client address the following business issues:
How do we identify and find qualified, substantial, and influential Key Opinion Leader ?
How can we indicate who are the efficient sets of Key Opinion Leader to invest given limited resource?
How do we reveal of that whom the targeted Key Opinion Leader can influent, moreover, who can influent our strategic Key Opinion Leader ?
Call Frequency & Segmentation Matrix
Sales force is one of the most valuable and expensive investments for any pharmaceutical company. The intricate nature of sales force size, structure and effort allocation requires an integrated analysis process. Through BalDr’s Call Frequency & Segmentation Matrix, we help our client devise the right sales force strategy for their product portfolio, optimize their resource allocation, and help them answer the following business questions:
How effective our current targeting approach is? Are your sales representatives covering the right doctors?
For each therapeutic area, what are the potentials among doctors and how many resources should I allocate on them?
Is the current sales force structure appropriate to cover the highly scattered potential hospitals and doctors?
Pharmaceutical Profitability Projection
Facing ever fiercer competition, pharmaceutical companies are struggling to optimize their portfolio management and further improve product lines' profitability. Therefore, a good Return on Investment analysis can identify independent investment mechanisms, indicate individual mechanism's performance, and ultimately influent business decisions. BalDr's breakthrough P3 Solution helps our client to solve the following business questions:
How can we derive comprehensive relationship between S&M activities and business performance?
How do we clarify what were the effective investing mechanisms and identify what were the best rewarding S&M activities?
How can we obtain a sustainable growth strategy and improve our investment efficiencies?
Competitive intelligence can be defined as the systematic gathering of information about competitors, such as products, Marketing and Sales strategy, Organization, and future pipelines, etc... With such valuable competitive data readily available, it is possible to capture relevant insight, and frame up responsive competition plans.
BalDr’s key intelligence topics help our client focus intelligence activities and form the basis of both discrete intelligence projects and ongoing efforts. The questions will be very specific and focused by disease area but broadly would cover:
What is the competitive set and the resource levels of key competitors?
What is the development and commercial strategy for key competitor companies?
What does the competitor pipeline look like?
Portfolio Management Optimizer
Under a rapidly changing healthcare environment - with reimbursement hurdles and uncertain commercial success, it requires pharmaceutical manufacturers to make thorough decisions about which treatments to pursue as well as to invest, in order to maximize overall potential at corporate-level.
Portfolio analysis is a systematic way to analyze the products and services that make up an association's business portfolio. It helps the company decide which product and service should be emphasized and which should be phased out, based on objective criteria. Through our Portfolio Management Optimizer, pharmaceutical companies should be able to answer the following questions:
How can we manage our portfolio for long-term sustainable value creation?
Which businesses should be our growth platforms going forward? Which can be our "cash machines?“
How should we differentiate goals, metrics, and incentives across the portfolio?
Per current competitive business scheme, how to conduct solid based and reasoned business decision is crucial to win the competitions. In order to do so, leveraging various source of information to aid business decision making process is the key competency for contemporary business leaders. Yet, current companies encounter a scattered source of information in both internal and external data source, and lack of adequate toolkit in converting diverse source of information into actionable intelligence.
In order to help our client mitigate information integration barriers, BalDr’s System Integration Solution can help you:
Collect information from both internal or external sources with our proprietary parser engine technology.
Intellectualize diverse information into structural intelligence as to be possible for analysis with customized end-to-end applications plus seamlessly accessibility.
Mobile Health (mHealth) Solutions
Traditionally, patients’ physical health condition are only examined and captured through medical records during periodic follow-ups. Thus, physicians are not able to monitor their patients’ condition as well as to give medical suggestions after the consultation. Furthermore, the information contained in these medical records doesn’t travel easily out of the practice, which in long term may cause unnecessary healthcare costs.
The advent of smartphones has taken the healthcare industry into a new level. This advanced computing capability that are typically optimized for internet usage has given rise of Mobile Health. It enables patients to access information throughout their patient journey and being advised or monitored from anywhere at any time. In sum, patient mobile applications can give the benefits as follow:
A shared information platform which go beyond settings as well as provides accurate and complete information about patient's healthcare history
Reduces unnecessary healthcare costs and enables healthcare professions to remote monitor their patients’ health condition
Electronic Patient Diary Study
A patient diary is a tool, which records patient's conditions. Paper diaries are the traditional type of diary recording method and are considered utmost authentic and unique information of patient. However, they do have some downfalls: researcher must wait until the diary is returned from the participant before starting analysis and the quality of the diary is also difficult to control.
BalDr’s electronic patient diary overcomes this drawbacks. We provide a web portal allowing physicians to use the most common and secure method of data entry. Our key features are highlighted as below:
Sustain diary quality with instant fill-in instruction
Able to monitor progress, timely remind to fill-in, and accelerate the field work process
Today, specialists across all kinds of industry can leverage proven innovations to put big data and analytics to work for them. However, the OncoCloud industry has not yet seen this revolution. For these reasons and many others, we decided to build the first advanced data platform that is truly dedicated to OncoCloud.
OncoCloud is similar to our Electronic Patient Diary (ePD) Solution but is relatively more complex. To create OncoCloud we assembled a world-class system engineering team to bring new approaches and fresh perspectives to the table. Our platform aggregates and transforms clinical data from physician’s office in real-time and has the unique features as listed below:
Timeliness: Data entering the OncoCloud platform is loaded on a real-time basis, allowing for near real-time learning and insights
Complete & Shareable Data: Significantly increases the completeness of key data elements and could be shared across settings
Academic & Business Insights: Installed with a flexible cloud-based analytical tool and visualization to quickly identify key trends and patterns
Patient Revisit Reminding System
The objective of the Patient Revisit Reminding System is to provide a “Web + Mobile” total solution for both patients and physicians and it renders the following benefits:
Enhance patient’s compliance in terms of consultation revisit
Establish a synchronized disease status sharing between physicians and patients, so to enhance treatment effectiveness
Aggregates and transforms real-world clinical data from physician’s office in real-time
To summarize, the Patient Revisit Reminding System has the below distinctive attributes:
Accurate Patient Revisit Monitoring
The system remotely tracks down the revisit schedule and reminds the patients/caregivers of the appointment by sending-out text messages
Sophisticated & Sharable Data
Users can thoroughly understand patients’ disease history and this information could also be shared across settings
Cloud-based & Seamless Interface
Our system secures 24/7 access via the internet and provides highly customizable to seamlessly users’ practice
Advanced Security (HIPAA Standard)
We use a multi-layered strategy across industry-best practices and state-of-the-art tools to ensure the data is safe.
Market Assessment/ATU Study
Throughout the product lifecycle, up-to-date market understanding is the critical foundation for the disease area, brand, and finally the franchise strategies. In the early stage of product life cycle, it is likely to involve broad disease market understanding activities, while in later stages, the activities become more focused on providing up-to-date understanding of key market issues and the competitive landscape that could impact the type and size of the opportunity of the brand. Via Market Assessment and ATU studies, they could help client to:
Identify disease area targets and evaluate the commercial opportunity of each target
Optimize brand performance through identifying key market issues, customer needs and competitor activities
Enable accurate measurement of how successful the brand is at achieving its strategic objectives
Market Access/Payer & Pricing Study
The environment for the pricing and reimbursement of pharmaceuticals has become increasingly challenging. Regulations has tightened and due to limited healthcare budget, cost-effectiveness of a certain drug has been more and more important in these markets .This shift has accelerated the emergence of a key group of influential stakeholders, namely payers. Pharmaceutical companies should put effort in understanding the needs of payers to develop an effective market access strategy so to receive a better price as well as to ensure the right information is communicated to drive product uptake.
In BalDr, we help to understand the needs of payers to develop an effective market access strategy and determine the optimum price, taking into account value delivered to policy makers/ influencers, prescribers and patients that will optimize profitability and sustainability.
Through our Market Access/Payer & Pricing Study, our clients will be able to dig out the answers of the following questions.
What level of evidence, both clinical and economical, is required to fulfill unmet needs?
What are the therapy endpoints as well as the clinical comparator to receive a better reimbursement price?
Are there any market access hurdles and challenges that need to be overcome?
What is the best way to communicate the core benefit and value of the product to payers?